Manufacturing USA headquarters

by | December 16, 2016

ABOVE: Secretary of Commerce Penny Pritzker announces the National Institute for Innovation in Manufacturing Biopharmaceuticals. | Photo by Evan Krape

Secretary of Commerce visits UD to announce new institute

Secretary of Commerce Penny Pritzker visited the University of Delaware today, where she announced a new institute to advance U.S. leadership in pharmaceutical manufacturing.

The Newark-based National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) will be the 11th Manufacturing USA Institute.

Biopharmaceuticals are prescription drugs made with living cells. Most drugs are chemistry-based and far easier to produce. The biopharmaceutical category includes vaccines, cancer drugs and drugs to treat autoimmune diseases, as well as emerging drugs for cell and gene therapies.

The institute will focus on bringing safe drugs to market faster and on developing workforce training. The biopharmaceutical field has a negative unemployment rate, with more jobs available than there are qualified workers.

A team of more than 150 companies, educational institutions, nonprofits and state governments will operate NIIMBL under a newly formed nonprofit.

Expected total investment from all stakeholders totals $250 million, including $70 million of federal investment.

The University of Delaware will handle administrative duties for the institute in partnership with the Commerce Department’s National Institute of Standards and Technology (NIST). Its headquarters will be on UD’s campus in a location to be determined.

UD Research on Twitter

TOP STORIES

Margaret Stetz

Margaret Stetz

As a scholar with diverse interests from 19th-century British literature to military history and fashion studies, and who shares her work in a variety of academic and community forums, Margaret D. Stetz might be expected to have difficulty summarizing what she does.

Dion Vlachos

A big spark for energy research

U.S. Department of Energy announces $12.8 million for UD-led center

regulatory affairs policy updates

Policy updates for protecting human subjects in research

Significant revisions to the “Common Rule” – a regulation that governs research involving human subjects conducted or sponsored by the Federal department and agencies that have adopted those rules – are expected to take full effect on January 21, 2019.

Share This